Thier Mark, Nordenström Erik, Almquist Martin, Bergenfelz Anders
Department of Clinical Sciences, Lund University, Lund, Sweden.
Department of Surgery, Skane University Hospital, Lund University, 221 85, Lund, Sweden.
World J Surg. 2016 Mar;40(3):582-8. doi: 10.1007/s00268-015-3360-6.
Since the introduction of unilateral parathyroidectomy for primary hyperparathyroidism (pHPT) it has been debated wherever this approach is associated with greater long-term risk for recurrence compared to bilateral neck exploration.
This is a prospective study based on a structured 15-year follow-up program in patients with non-hereditary, sporadic pHPT, undergoing first time surgery with unilateral or focused neck exploration (unilateral procedures), with the use of intraoperative PTH (iOPTH) between 1989 and 2010.
292 patients were analyzed. The median age of the patients was 66 years [interquartile range (IQR) 57-75], and 234 (80.4%) were female. The median preoperative level of total calcium was 2.74 mmol/L (IQR 2.63-2.85 mmol/L) and the median PTH level was 10 pmol/L (IQR 7.4-14 pmol/L). The median follow-up time was 5 years (IQR 1-10 years). Some 275 patients were followed for 1 year (94.2%/275 person-years/5 patients deceased), 164 for 5 years (56.2%/820 person-years/31 patients deceased), 70 for 10 years (24.0%/700 patient-years/57 patients deceased) and 51 (17.5%/765 patient-years/69 patients deceased) for 15 years after surgery. Three patients (1.1%) had signs of persistent disease. One patient recurred in pHPT at 5 years postoperatively during 15 years of follow-up. Histopathology indicated solitary parathyroid adenoma at primary surgery.
Patients with pHPT operated with unilateral procedures and iOPTH, had a low risk for long-term recurrence during a 15 years follow-up program.
自从引入原发性甲状旁腺功能亢进症(pHPT)的单侧甲状旁腺切除术以来,与双侧颈部探查相比,这种方法是否会带来更高的长期复发风险一直存在争议。
这是一项前瞻性研究,基于对1989年至2010年间首次接受单侧或局限性颈部探查(单侧手术)的非遗传性、散发性pHPT患者进行的结构化15年随访计划,术中使用了甲状旁腺激素(iOPTH)。
对292例患者进行了分析。患者的中位年龄为66岁[四分位间距(IQR)57 - 75],234例(80.4%)为女性。术前总钙的中位水平为2.74 mmol/L(IQR 2.63 - 2.85 mmol/L),甲状旁腺激素的中位水平为10 pmol/L(IQR 7.4 - 14 pmol/L)。中位随访时间为5年(IQR 1 - 10年)。约275例患者随访了1年(94.2%/275人年/5例患者死亡),164例随访了5年(56.2%/820人年/31例患者死亡),70例随访了10年(24.0%/700人年/57例患者死亡),51例(17.5%/765人年/69例患者死亡)术后随访了15年。3例患者(1.1%)有持续性疾病的体征。在15年的随访期间,1例患者在术后5年出现pHPT复发。组织病理学显示初次手术时为孤立性甲状旁腺腺瘤。
在15年的随访计划中,接受单侧手术和iOPTH治疗的pHPT患者长期复发风险较低。